Full article view 2017-09-21T12:14:01+00:00
Back to News & Insights »

Press Release: Precision for Medicine Launches New Business Units Focused on Demonstrating Product Value and Supporting Commercial Excellence

(BETHESDA, MD) November 18, 2014 – Precision for Medicine, Inc., formed in 2012 to support next-generation approaches to drug development and commercialization, announces the launch of a new strategic business unit and adjacent global life sciences consulting firm focused directly on the demonstration of product value. The solutions, Precision for Value and Precision Advisors, will deliver strategic support, development, and communication of product value for clients in the pharmaceutical and life sciences industries.

“New medical technologies, combined with an evolving payer landscape, are changing what it means to demonstrate value to a rapidly expanding set of decision makers,” said Ethan Leder, CEO of Precision for Medicine. Leder continued, “Building on previously announced acquisitions, we continue to create a unique and comprehensive service offering for our clients that integrates evidence generation, analytics, and communications, specifically designed for the patient-centric, multipayer landscape that will define the future of healthcare. These new business units intensify our focus on commercial excellence in the era of precision medicine.”

Building from the acquisition of Hobart Group Holdings in 2013 and Core Access Group in 2014, Precision for Value  supports commercial excellence for global pharmaceutical and life sciences clients focused on value-driven market access and outcomes. At launch, Precision for Value supports more than 60 brands for over 30 large, midsize, and emerging biopharmaceutical clients. With an experienced team of more than 200 employees across 6 locations, clients are provided extensive strategic and tactical support for integrated market access initiatives in the United States and key global markets.

Precision Advisors combines unrivaled real-world market experience with thought leadership and industry expertise to provide insight, strategy and advice to pharmaceutical and life sciences companies in realizing the value of their products and services in the evolving and complex healthcare marketplace. An industry leading team of more than 40 advisors offers a wealth of experience across the commercialization spectrum, including research and clinical development of targeted therapies and diagnostics, clinical solutions, regulatory guidance, health economics design, launch planning, access strategy, promotional effectiveness, and market adoption.

“The formation of Precision for Value and Precision Advisors supports our commitment to delivering consistently innovative solutions to the many great clients we serve,” commented Dan Renick, Co-President and Chief Commercial Officer of Precision for Medicine. “Throughout our history, we have strived to be an invaluable partner in guiding strategy, securing access and driving market adoption for innovative medical products, and we’re building on that success by integrating critical new capabilities to improve efficiency and effectiveness in achieving commercial excellence for our clients.”

 About Precision for Medicine
Precision for Medicine is a specialized company providing services and infrastructure to support life sciences companies as they develop new products in the age of precision medicine. Precision brings expertise, technology, and project execution to support innovative, patient-centric solutions from discovery through commercialization. The company is headquartered in Bethesda, MD. Visit www.precisionformedicine.com for more information.

 About Precision for Value
Precision for Value supports commercial excellence for global pharmaceutical and life sciences clients through the proficient demonstration of product value and outcomes. With locations in New York City, New Jersey, Chicago, Boston, Connecticut, and Indianapolis, Precision for Value’s teams provide clients with services grounded in decades of industry knowledge, demonstrated analytics proficiency, and marketing and communications prowess— making Precision for Value the preferred strategic partner in the industry. Visit www.precisionforvalue.com for more information.

 About Precision Advisors
Precision Advisors combines unrivaled real-world market experience with thought leadership and industry expertise to provide insight, strategy and advice to innovative life science companies. Headquartered in Cambridge, Massachusetts, Precision Advisors’ unrivaled team of expert advisors encompass all areas of the commercialization spectrum including strategy consulting, managed markets, health economics, clinical research and analytics. Visit www.pfmadvisors.com to learn more about how the expertise of Precision Advisors can inform your success.

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.